2022 IARC/NCI Joint Workshop on HIV and Cancer
, by Jennifer K. Loukissas, M.P.P.
Participants in the NCI-IARC Workhop on HIV and Cancer
The International Agency for Research on Cancer (IARC) and the U.S. National Cancer Institute (NCI) convened ~30 international experts on HIV and cancer on September 12-13, 2022, in Rockville, MD, at the NCI at Shady Grove.
The participants focused on the state of the science, gaps in research, opportunities for future studies, and barriers and challenges in the field. Topics included cancer incidence, screening, treatment and survival, and tumor characteristics for cancers among people living with HIV. Additional sessions focused in-depth on cervical cancer and Kaposi sarcoma in people living with HIV.
The workshop was organized by Eric A. Engels, M.D., M.P.H., Chief and senior investigator, and Meredith Shiels, Ph.D., M.S., senior investigator, both of the Infections and Immunoepidemiolgy Branch, and Dr. Gary Clifford, Deputy Branch Head, Early Detection, Prevention, and Infections, IARC. This meeting was the sixth in a series of workshops co-hosted by the two organizations.
"This meeting was extremely helpful in identifying some of the key research opportunities in the field of HIV and cancer,” said Dr. Engels. “It was great to be able to meet in person to discuss these topics."
Welcoming remarks were made by Stephen J. Chanock, M.D., Director, DCEG, and Dr. Paul Brennen, Branch Head of the Genetics Section/Genomic Epidemiology at IARC.
DCEG speakers from IIB included Drs. Engels and Shiels; Megan E. Clarke, Ph.D., M.H.S., Earl Stadtman investigator in the Clinical Genetics Branch, also presented.
Former fellows Drs. Hilary Robbins, from IARC, and Anna Cogill from Moffitt Cancer Center, also presented.